drugset / Trial / NCT04151823

Effect of POSTbiotics Supplementation on Microbiome in OBese Children: the POST-OB Study

NCT04151823

Phase 4 Unknown 30 enrolled University of Milan
NaSingle-groupOpen-labelTreatment

Summary

This study evaluates the possible effect of postbiotics supplementation, combined with interventions aimed at improving diet and lifestyle, on gut microbiota composition and metabolite production. It also wants to determine whether postbiotics supplementation, combined with interventions to improve diet and lifestyle, reduces adverse metabolic consequences together with their co-morbidities. All participants will follow a behaviour (promotion of physical activity) and dietary treatment according to Italian dietary guidelines for childhood obesity. Postbiotics and vitamin D3 will be given orally for four months; patients will be evaluated four months after supplementation and diet-lifestyle intervention and four months after the end of supplementation and after the alone diet-lifestyle intervention with blood testing and echosonography of the liver.

Timeline

Start
2019-01-07
Primary completion
2021-01-07
Completion
2021-01-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Immunofos Unknown 80 mg Oral
Background Cholecalciferol Other / unclassified 1600 iu Oral

Indications

No indication recorded.